Policy/DirectionThe CEO took a massive risk going it the way of a R&D company!
They barely earned enough money from their 2 drugs and had no cash nor partners. He diluted with a terrible OO and after that took a loan on terrible conditions!
He would be a hero now if oncology was a succes but unfortunately it doesn't work that easy. Look at the many companies in oncology, costly trials/long duration.
He had 0 risk, earned his money and will silently disappear to get another "job".
Leaving TH with the words..............hope and luck!!
GLA